The role of zinc lozenges in treatment of the common cold

被引:22
作者
Garland, ML
Hagmeyer, KO
机构
[1] Univ Toledo, Coll Pharm, Toledo, OH 43606 USA
[2] John Cochran Vet Affairs Med Ctr, St Louis, MO USA
关键词
zinc acetate; zinc gluconate; common cold;
D O I
10.1345/aph.17128
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: To summarize and critique the medical literature on the use of zinc lozenges for treatment of the common cold. DATA SOURCES: MEDLINE searches (January 1966-June 1997) identified human clinical trials on the use of zinc lozenges for the treatment of the common cold. Bibliographies were also reviewed for relevant articles. STUDY SELECTION: Double-blind, placebo-controlled trials of zinc lozenges in adults for the treatment of the common cold, with the clinical end points of reduction in duration and/or severity of cold symptoms. DATA EXTRACTION: All double-blind, placebo-controlled, human clinical trials on the use of zinc lozenges for the treatment of the common cold were included. DATA SYNTHESIS: The use of zinc lozenges in the treatment of the common cold has been suggested to reduce the duration and severity of cold symptoms. Of eight double-blind, placebo-controlled trials, four found zinc lozenges to be effective, while the other four reported no difference between zinc and placebo therapy. Potential reasons for the discrepancy between the results of these trials include inadequate placebo control, formulation of the lozenge, and the dose of zinc used. Common adverse effects include unpleasant taste, mouth irritation, and nausea. CONCLUSIONS: Treatment of the common cold with zinc gluconate lozenges, using adequate doses of elemental zinc, may be effective in reducing duration and severity of cold symptoms. The benefit appears to be maximal if the lozenges are started immediately after the onset of symptoms. The formulation of the lozenges also appears to be important because the addition of citric acid or tartaric acid may reduce efficacy due to chelation of zinc ion. Although zinc gluconate lozenges have dominated clinical trials thus far, further studies are needed to demonstrate the efficacy of zinc acetate lozenges and to determine whether their adverse effect profile is more favorable to that of zinc gluconate lozenges. Patients should play an important role in the decision-making process and must decide whether the benefit gained from treatment with zinc lozenges outweighs the potential adverse effects.
引用
收藏
页码:63 / 69
页数:7
相关论文
共 30 条
[1]   PROPHYLAXIS AND TREATMENT OF RHINOVIRUS COLDS WITH ZINC GLUCONATE LOZENGES [J].
ALNAKIB, W ;
HIGGINS, PG ;
BARROW, I ;
BATSTONE, G ;
TYRRELL, DAJ .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1987, 20 (06) :893-901
[2]  
BASHFORD CL, 1986, J BIOL CHEM, V261, P9300
[3]  
BERTHON G, 1984, AGENTS ACTIONS, V22, P231
[4]   COMPLEXES OF COPPER(II), CALCIUM, AND OTHER METAL-IONS WITH CARBOHYDRATES - THIN-LAYER LIGAND-EXCHANGE CHROMATOGRAPHY AND DETERMINATION OF RELATIVE STABILITIES OF COMPLEXES [J].
BRIGGS, J ;
FINCH, P ;
MATULEWICZ, MC ;
WEIGEL, H .
CARBOHYDRATE RESEARCH, 1981, 97 (02) :181-188
[5]   EXCESSIVE INTAKE OF ZINC IMPAIRS IMMUNE-RESPONSES [J].
CHANDRA, RK .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1984, 252 (11) :1443-1446
[6]   ELECTRON-MICROSCOPIC DEMONSTRATION OF METALS IN RAT MAST-CELLS - A CYTOCHEMICAL STUDY BASED ON AN IMPROVED SULFIDE SILVER METHOD [J].
DANSCHER, G ;
OBEL, J ;
THORLACIUSUSSING, O .
HISTOCHEMISTRY, 1980, 66 (03) :293-300
[7]   FAILURE OF EFFERVESCENT ZINC ACETATE LOZENGES TO ALTER THE COURSE OF UPPER RESPIRATORY-TRACT INFECTIONS IN AUSTRALIAN ADULTS [J].
DOUGLAS, RM ;
MILES, HB ;
MOORE, BW ;
RYAN, P ;
PINNOCK, CB .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (08) :1263-1265
[8]   REDUCTION IN DURATION OF COMMON COLDS BY ZINC GLUCONATE LOZENGES IN A DOUBLE-BLIND-STUDY [J].
EBY, GA ;
DAVIS, DR ;
HALCOMB, WW .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 25 (01) :20-24
[10]   Zinc lozenges as cure for common colds [J].
Eby, GA .
ANNALS OF PHARMACOTHERAPY, 1996, 30 (11) :1336-1338